![Jürgen Raths](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jürgen Raths
Corporate Officer/Principal presso Executive Insight AG
Posizioni attive di Jürgen Raths
Società | Posizione | Inizio | Fine |
---|---|---|---|
Executive Insight AG | Corporate Officer/Principal | 01/01/2015 | - |
Storia della carriera di Jürgen Raths
Precedenti posizioni note di Jürgen Raths
Società | Posizione | Inizio | Fine |
---|---|---|---|
PAION AG | Direttore operativo | 31/08/2015 | 01/03/2017 |
Advanz Pharma Switzerland SARL
![]() Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Amministratore Delegato | 01/01/2010 | 01/01/2013 |
Presidente | 01/01/2010 | 01/01/2013 | |
Arpida AG
![]() Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Presidente | 01/05/2008 | 14/12/2009 |
Eli Lilly (Suisse) SA | Corporate Officer/Principal | 01/01/1990 | 01/01/2008 |
Vesselon, Inc.
![]() Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Direttore/Membro del Consiglio | - | - |
Formazione di Jürgen Raths
University of Bonn | Doctorate Degree |
Statistiche
Distribuzione geografica
Svizzera | 5 |
Germania | 3 |
Stati Uniti | 2 |
Posizioni
President | 2 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PAION AG | Health Technology |
Aziende private | 5 |
---|---|
Arpida AG
![]() Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Advanz Pharma Switzerland SARL
![]() Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Health Technology |
Eli Lilly (Suisse) SA | |
Executive Insight AG | |
Vesselon, Inc.
![]() Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
- Borsa valori
- Insiders
- Jürgen Raths
- Esperienza